Scientific Reports · 2018 · 82 citations · 24 references
MedicineDermatologyImmunologyHypersensitivityImmunopathologyInflammationAtopic DermatitisContact AllergyContact DermatitisCytokine BiologyImmunopathology Of SkinSkin SensitizationAtopic Dermatitis Contact SensitizationAtopic Dermatitis ImmunopathologyAtopic Dermatitis PathogenesisElicitationSensitizationSensitization PhaseTh2 Immune ResponseTransgenic Mice
Abstract IL-31, which is a member of the IL-6 family of cytokines, is produced mainly by activated CD4 + T cells, in particular activated Th2 cells, suggesting a contribution to development of type-2 immune responses. IL-31 was reported to be increased in specimens from patients with atopic dermatitis, and IL-31-transgenic mice develop atopic dermatitis-like skin inflammation, which is involved in the pathogenesis of atopic dermatitis. However, the role of IL-31 in development of contact dermatitis/contact hypersensitivity (CHS), which is mediated by hapten-specific T cells, including Th2 cells, is not fully understood. Therefore, we investigated this using IL-31-deficient ( Il31 −/− ) mice, which we newly generated. We demonstrated that the mice showed normal migration and maturation of skin dendritic cells and induction of hapten-specific T cells in the sensitization phase of FITC-induced CHS, and normal induction of local inflammation in the elicitation phase of FITC- and DNFB-induced CHS. On the other hand, those mice showed reduced scratching frequency and duration during FITC- and/or DNFB-induced CHS. Our findings suggest that IL-31 is responsible for pruritus, but not induction of local skin inflammation, during CHS induced by FITC and DNFB.
24
Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Thomas Ruzicka, Jon M. Hanifin, Masutaka Furue et al. · New England Journal of Medicine · 2017 · 587 citations · Full text
Medicine, Dermatology, Immunology +15